ADME Study of [14C]-Ibrexafungerp in Healthy Male Subjects
Clinical trial NCT04307082 · COMPLETED
Trial details
- NCT number
- NCT04307082
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2020-05-29
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.